Cerebrine (peptide complex) solution for injection
24245USD

Cerebrine (peptide complex) solution for injection

SKU:2183
To favorites
Cerebrine (peptide complex) The drug has an organ-specific multimodal effect on the brain, neuroprotection, functional neuromodulation and neurotrophic activity, improves intracellular protein synthesis in the developing and aging brain
Active substance:peptide complex
Pharmacological group:Nootropic
Formulation:ampoules
Country of origin:Russia
In stock
$42
11
Description
Features
Reviews

Instructions for Cerebrine (peptide complex) solution for injection

Brief description Cerebrine

Clinical-pharmacological group: Nootropic drug.
Pharmacotherapy group: Nootropic agent.
Dosage form: solution for injection.

Description peptide complex Cerebrine:

The translucent solution is yellowish to yellowish brown.

Testimony peptide complex nootropic

  • Alzheimer's disease
  • dementia syndrome of different genesis
  • chronic cerebrovascular insufficiency
  • ischemic stroke
  • traumatic brain and spinal cord injuries
  • Delayed mental development in children
  • hyperactivity and attention deficit in children
  • in complex therapy for endogenous depression
  • resistant to antidepressants.

Pharmacological effect Cerebrine:

Pharmacodynamics
Cerebrin contains low-molecular biologically active neuropeptides that penetrate the blood-brain barrier and directly reach the nerve cells. The drug has an organospecific multimodal effect on the brain, i.e. it provides metabolic regulation, neuroprotection, functional neuromodulation and neurotrophic activity.
Metabolic regulation: Cerebrin increases the efficiency of aerobic energy metabolism in the brain, improves intracellular protein synthesis in the developing and aging brain.

Composition Cerebrine

1 ml contains peptide complex:
The complex of peptides derived from the pig brain is 215.2 mg.
Auxiliary substances: sodium hydroxide - 2.1 mg, water d/i - up to one ml.

Method of use and dosage peptide complex:

Applied parenterally. The dose and duration of treatment depends on the nature and severity of the disease, as well as the age of the patient. Single doses of up to 50 ml may be prescribed, but treatment is preferred.
The recommended optimal course of treatment is daily injections for ten to twenty days.
Acute conditions (ischemic stroke, traumatic brain injury, complications of neurosurgical operations): 10 ml to 50 ml.
In the reconstructive period of brain stroke and traumatic brain and spinal cord injury: 5 ml to 50 ml.
In psychoorganic syndrome and depression: five to thirty ml.

Features
Active substance
Pharmacological group
Formulation
Country of origin
Expiration Date
No reviews yet — your comment may be first.
All reviews 0
general rating